Shares Held (Direct Ownership) 25.7K
n/a 3M change
n/a 12M change
Total Value Held N/A

Mike Mensinger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2025
SELL
Open market or private sale
$221 $17.0 p/Share
13 Reduced 0.05%
25,669 Common Stock
Jan 31 2025
BUY
Exercise of in-the-money or at-the-money derivatives securities
$211 $0.02 p/Share
10,575 Added 29.17%
25,682 Common Stock
Jan 31 2025
BUY
Conversion of derivative security
-
15,107 Added 50.0%
15,107 Common Stock
Jan 31 2025
BUY
Open market or private purchase
$566,950 $17.0 p/Share
33,350 Added 36.11%
59,019 Common Stock
MM

Mike Mensinger

Chief Product Officer
Irvine, CA

Track Institutional and Insider Activities on BBNX

Follow Beta Bionics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBNX shares.

Notify only if

Insider Trading

Get notified when an Beta Bionics, Inc. insider buys or sells BBNX shares.

Notify only if

News

Receive news related to Beta Bionics, Inc.

Track Activities on BBNX